These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31061182)

  • 1. Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab.
    Loh CH; Herkes G
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31061182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report.
    Tireli D; He J; Nordling MM; Wienecke T
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e123-e125. PubMed ID: 28479184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis.
    Ng FC; Bice J; Rodda A; Lee-Archer M; Crompton DE
    J Neurol; 2017 Mar; 264(3):591-594. PubMed ID: 28168523
    [No Abstract]   [Full Text] [Related]  

  • 4. Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation.
    Tsai YT; Hsiao YJ; Tsai LK; Yen PS; Lin FY; Lu CH; Fang CW
    J Neurol Sci; 2018 May; 388():155-157. PubMed ID: 29627012
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
    Agosti S; Casalino L; Rocci E; Zaccone G; Rota E
    J Med Case Rep; 2017 Aug; 11(1):224. PubMed ID: 28806993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J; Sabovic M; Frol S
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke - a single centre experience.
    Włodarczyk E; Sawczyńska K; Wrona P; Słowik A
    Neurol Neurochir Pol; 2023; 57(6):465-476. PubMed ID: 37955597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report.
    Laxamana LC; Co COC; Yu JRT; Mojica CV; Iboleon-Dy MAM; Domingo AMC; Ilano KCS; Macrohon-Valdez MCZ
    Clin Ther; 2020 Sep; 42(9):1840-1845. PubMed ID: 32778345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab-A Case Report.
    Schäfer N; Müller A; Wüllner U
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):e126-7. PubMed ID: 27236361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic thrombolysis after the administration of idarucizumab in acute ischemic stroke].
    Pásztor M; Bereczki D; Szakács Z; May Z
    Ideggyogy Sz; 2017 Jul; 70(7-8):284-288. PubMed ID: 29870643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
    Meyer D; Chu F; Derry K; Hailey L
    J Clin Neurosci; 2019 Jan; 59():355-357. PubMed ID: 30309801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idarucizumab elimination of dabigatran minutes before systemic thrombolysis in acute ischemic stroke.
    Schulz JG; Kreps B
    J Neurol Sci; 2016 Nov; 370():44. PubMed ID: 27772783
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous stroke thrombolysis after reversal of dabigatran effect by idarucizumab: first reported case in Hong Kong.
    Lo WT; Ng KF; Chan SC; Kwok VW; Fong CS; Chan ST; Wong GC; Fong WC
    Hong Kong Med J; 2018 Feb; 24(1):81-3. PubMed ID: 29424347
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Berrouschot J; Stoll A; Hogh T; Eschenfelder CC
    Stroke; 2016 Jul; 47(7):1936-8. PubMed ID: 27301937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
    Ohtani T; Sintoku R; Yajima T; Kaneko N
    J Med Case Rep; 2019 Dec; 13(1):390. PubMed ID: 31875786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute stroke thrombolysis following dabigatran reversal using idarucizumab.
    Harsha KJ; Thirunavukkarasu S; Butcher K
    Neurol India; 2019; 67(2):568-570. PubMed ID: 31085880
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
    Ohya Y; Makihara N; Wakisaka K; Morita T; Ago T; Kitazono T; Takaba H
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e128-e131. PubMed ID: 29555397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.